Mitsubishi Chemical Group (hereinafter referred to as "the Company Group") has decided to transfer part of the real estate leasing and management business of Dialyx Corporation (hereinafter referred to as "Dialyx") along with the related Shareholding real estate to Japan Escon Corporation (hereinafter referred to as "Japan Escon").

1. Reason for the transfer

Dialyx, a wholly owned subsidiary of the Company Group, has been engaged in the leasing and management business of its Shareholding real estate as part of its real estate business commenced in 1961. However, in light of the increasing trend in repair costs related to the Shareholding real estate, it was determined to be appropriate to transfer part of the leasing and management business along with the Company Group's related Shareholding real estate to Japan Escon, which develops Real Estate Development projects throughout Japan, and thus this decision was made.

2. Transfer targets

• Part of Dialyx's real estate leasing and management business
• The Company Group's Shareholding real estate related to that business

3. Overview of the transferee

Company name: Japan Escon Corporation
Location: 20th Floor, Okura Prestige Tower, 2-10-4 Toranomon, Minato-ku, Tokyo.
Main business: residence sales, real estate development, real estate leasing, asset management, and other businesses.

4. Transfer date.

Scheduled for April 1, 2025.
■For reference: Overview of Daiyarex.
Company name: Daiaricks Co., Ltd.
Location: 1-30 2-chome, Shiba, Minato-ku, Tokyo (Hirakuka Building).
Shareholders: Mitsubishi Chemical Corporation 100%.
Number of employees: 530 (as of the end of March 2024).
Main businesses: insurance brokers, a-reit etf, business resistance